Additional information
| Active substance | Selegiline |
|---|---|
| Classification | Monoamine Oxidase Type B (MAO-B) Inhibitors |
| Water Retention | Minimal or none |
| Hepatotoxicity | Low risk |
| Lab Test | Drug specific blood tests available for therapeutic monitoring or overdose assessment |
| Also known as | L-deprenyl |
| WAREHOUSE | International Warehouse 1 |
| Blood pressure | May cause orthostatic hypotension |
| Trade name | Eldepryl, Zelapar |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | N-(1-phenylpropan-2-yl)-N-methylprop-2-yn-1-amine |
| Formula | C13H17N |
| Substance class | Monoamine oxidase inhibitor |
| Main action | Selective inhibition of monoamine oxidase B (MAO-B) |
| Half-life | 1.5 to 2 hours |
| Dosage (medical) | Typically 5-10 mg per day |
| Dosage (sports) | Not typically used in sports |
| Effects | Enhances dopaminergic activity, neuroprotective effects |
| Side effects | Orthostatic hypotension, dizziness, nausea, insomnia, confusion |
| Use in sports | None |
| Manufacturer | Intas Pharmaceuticals |
